Is Intrachromosomal Amplification of Chromosome 21 (iAMP21) Always Intrachromosomal?

Karen D. Tsuchiya(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Billy Davis

Cancer Genetics

May 1, 2016

10.1016/j.cancergen.2016.05.009

Cited by 0

Related Papers

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

|Transplantation and Cellular Therapy|2018|3.6k

Current concepts in the diagnosis and management of cytokine release syndrome

|Blood|2014|2.8k

CD19 CAR T cell product and disease attributes predict leukemia remission durability

|Journal of Clinical Investigation|2019|355

Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis

|Nature Medicine|2021|319

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

|Blood|2019|287